SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-18-004240
Filing Date
2018-11-30
Accepted
2018-11-30 17:27:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 INTELLIPHARMACEUTICS INTERNATIONAL INC. p18-2176sc13g.htm SC 13G 115406
  Complete submission text file 0000902664-18-004240.txt   116985
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

IRS No.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Subject) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G | Act: 34 | File No.: 005-85064 | Film No.: 181212107
SIC: 2834 Pharmaceutical Preparations